Concepedia

Author

Jeffrey L. Rossio

National Cancer Institute

Also Known As

J L Rossio, J Rossio, J. L. Rossio, J. Rossio, J.L. Rossio, JEFFREY L. ROSSIO, Jeffrey L Rossio, Jeffrey L. Rossio, Jeffrey L. Rossio,, Jeffrey Rossio

53

Publications

2.8K

Citations

23

H-Index

75

Concepts

All Affiliations

National Cancer InstituteScience Applications International Corporation (United States)National Institutes of HealthGilead Sciences (United States)National Institute of Allergy and Infectious Diseases
JL

About

Jeffrey L. Rossio is an author at National Cancer Institute specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

20

1.3K

2

Allergy

7

7

739

3

Health Sciences

1

1

44

4

Natural Sciences

1

1

265

5

Anesthesia

1

1

12

Jeffrey L. Rossio

×

32

Publications

2.5K

Citations

21

H-Index

YearCitations

Inactivation of Human Immunodeficiency Virus Type 1 Infectivity with Preservation of Conformational and Functional Integrity of Virion Surface Proteins

Jeffrey L. Rossio, M. T. Esser, K. Suryanarayana,

Journal of Virology

1998

413

Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide.

Adam Lee Goldstein, Teresa L. K. Low, Martha H. McAdoo,

Proceedings of the National Academy of Sciences

1977

359

The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus.

Teresa L. K. Low, Gary B. Thurman, Martha H. McAdoo,

Journal of Biological Chemistry

1979

265

Role of CD8 <sup>+</sup> Lymphocytes in Control of Simian Immunodeficiency Virus Infection and Resistance to Rechallenge after Transient Early Antiretroviral Treatment

Jeffrey D. Lifson, Jeffrey L. Rossio, Michael Piatak,

Journal of Virology

2001

263

The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection

Jeffrey D. Lifson, Martin A. Nowak, S Goldstein,

Journal of Virology

1997

231

Containment of Simian Immunodeficiency Virus Infection: Cellular Immune Responses and Protection from Rechallenge following Transient Postinoculation Antiretroviral Treatment

Jeffrey D. Lifson, Jeffrey L. Rossio, Ramy Arnaout,

Journal of Virology

2000

145

Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine.

L O Arthur, Julian W. Bess, E N Chertova,

PubMed

1998

114

Evaluation of the Safety, Immunogenicity, and Protective Efficacy of Whole Inactivated Simian Immunodeficiency Virus (SIV) Vaccines with Conformationally and Functionally Intact Envelope Glycoproteins

Jeffrey D. Lifson, Jeffrey L. Rossio, Michael Piatak,

AIDS Research and Human Retroviruses

2004

84

HLA Class II on HIV Particles Is Functional in Superantigen Presentation to Human T Cells: Implications for HIV Pathogenesis

Jeffrey L. Rossio, LOUIS E. HENDERSON, Peter Cresswell,

AIDS Research and Human Retroviruses

1995

74

Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.

C. Ewel, Walter J. Urba, William C. Kopp,

PubMed

1992

57

Page 1